Real World Efficacy of First-Line Immunotherapy plus /Chemotherapy in Advanced NSCLC Stratified by Serum Proteomics

被引：0

作者：

Akerley, W. ^{[1
]}

Halawani, H. ^{[2
]}

Schaefer, E. ^{[3
]}

Page, R. ^{[4
]}

Ghabach, B. ^{[5
]}

Evans, J. ^{[6
]}

Shunyakov, L. ^{[7
]}

Oubre, D. ^{[8
]}

Veatch, A. ^{[9
]}

Akulian, J. ^{[10
]}

Velcheti, V. ^{[11
]}

Pitcher, T. ^{[12
]}

机构：

[1] Huntsman Canc Inst, Salt Lake City, UT USA

[2] St Frances Cabrini Hosp, Canc Ctr, Alexandria, LA USA

[3] Highlands Oncol Grp, Fayetteville, AZ USA

[4] Ctr Canc & Blood Disorders, Ft Worth, TX USA

[5] JPS Ctr Canc Care, Ft Worth, TX USA

[6] Lewis & Faye Manderson Canc Ctr, Tuscaloosa, AL USA

[7] Cent Care Canc Ctr, Bolivar, CO USA

[8] Pontchartrain Canc Ctr, Covington, LA USA

[9] Northwest Med Specialties, Tacoma, WA USA

[10] UNC Med Ctr, Chapel Hill, NC USA

[11] NYU Laura & Isaac Perlmutter Canc Ctr, New York, NY USA

[12] Biodesix Co, Boulder, CO USA

来源：

关键词：

immunotherapy; biomarker; Real-world data;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2.07-06

引用

页码：S325 / S325

页数：1